A detailed history of Cibc World Market Inc. transactions in Essa Pharma Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 73,587 shares of EPIX stock, worth $120,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,587
Previous 80,257 8.31%
Holding current value
$120,682
Previous $422,000 5.69%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$4.45 - $7.1 $29,681 - $47,357
-6,670 Reduced 8.31%
73,587 $446,000
Q2 2024

Aug 07, 2024

SELL
$4.63 - $8.42 $2,778 - $5,052
-600 Reduced 0.74%
80,257 $422,000
Q1 2024

May 13, 2024

SELL
$6.17 - $10.65 $190,301 - $328,477
-30,843 Reduced 27.61%
80,857 $686,000
Q4 2023

Feb 13, 2024

SELL
$2.74 - $7.35 $102,593 - $275,206
-37,443 Reduced 25.11%
111,700 $737,000
Q3 2023

Nov 13, 2023

SELL
$2.65 - $3.31 $30,475 - $38,065
-11,500 Reduced 7.16%
149,143 $461,000
Q2 2023

Aug 11, 2023

SELL
$2.6 - $3.34 $125,184 - $160,814
-48,148 Reduced 23.06%
160,643 $434,000
Q1 2023

May 12, 2023

BUY
$2.56 - $3.55 $110,464 - $153,182
43,150 Added 26.05%
208,791 $620,000
Q4 2022

Feb 13, 2023

BUY
$1.5 - $4.82 $132,607 - $426,112
88,405 Added 114.46%
165,641 $417,000
Q3 2022

Nov 10, 2022

SELL
$1.75 - $3.44 $30,348 - $59,656
-17,342 Reduced 18.34%
77,236 $141,000
Q2 2022

Aug 10, 2022

SELL
$3.15 - $7.94 $65,060 - $163,992
-20,654 Reduced 17.92%
94,578 $298,000
Q1 2022

May 12, 2022

BUY
$6.18 - $14.44 $191,592 - $447,668
31,002 Added 36.81%
115,232 $712,000
Q4 2021

Feb 14, 2022

BUY
$7.8 - $14.38 $656,994 - $1.21 Million
84,230 New
84,230 $1.2 Million
Q1 2021

May 11, 2021

SELL
$11.61 - $32.08 $116,680 - $322,404
-10,050 Closed
0 $0
Q2 2018

Aug 08, 2018

BUY
$3.2 - $4.74 $32,160 - $47,637
10,050 New
10,050 $38,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $72.3M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.